Short answer
Merck & Co. (MRK) filed an 8-K current report with the SEC on November 18, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1). Thomas H. Glocer retiring from Merck’s Board at the 2027 Annual Meeting.
Merck & Co. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Thomas H. Glocer retiring from Merck’s Board at the 2027 Annual Meeting
- Departure not related to disagreements, reducing governance disruption and transition risk
Item EX-99.1 · Exhibit EX-99.1
- Thomas H. Glocer to retire from Merck’s Board at the May 2027 annual meeting
- Douglas M. Baker Jr. appointed independent lead director effective January 1, 2027
- Leadership transition preserves board continuity, with Baker serving as a director since 2022
- Baker brings former Ecolab chairman and CEO experience, strengthening governance and operational oversight
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Merck & Co. 8-K filings
Get the next MRK 8-K as it lands
Follow MRK for push alerts, or ask the research agent what this filing means.